Impact Partnership Wealth’s Genmab GMAB Stock Holding History

Impact Partnership Wealth’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-46	Closed	-$1.75K	–	1086
2023 Q2	$1.75K	Buy	+46	New	+$1.83K	﹤0.01%	705

Other funds holding GMAB

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Impact Partnership Wealth's GMAB Position: Q3 2023 in Review

Impact Partnership Wealth sold out of Genmab (GMAB) in Q3 2023, closing a stake of 46 shares — an estimated $1.75K sold.

Impact Partnership Wealth first reported a position in GMAB in Q2 2023 and held it in 1 quarter. The position peaked at $1.75K in Q2 2023. 233 funds tracked by Wall St. Rank hold GMAB as of Q3 2023.

Impact Partnership Wealth reported no remaining Genmab position as of Q3 2023 after selling out during the quarter.
Impact Partnership Wealth sold 46 Genmab shares in Q3 2023, an estimated $1.75K.
Impact Partnership Wealth first reported a position in Genmab in Q2 2023 and held it in 1 quarter.
Impact Partnership Wealth's Genmab position peaked at $1.75K in Q2 2023.
233 funds tracked by Wall St. Rank held Genmab as of Q3 2023.

Based on Impact Partnership Wealth's 13F filing for Q3 2023, filed 17 Oct 2023.